vs
Side-by-side financial comparison of KILROY REALTY CORP (KRC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $272.2M, roughly 1.8× KILROY REALTY CORP). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.3%, a 0.5% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -5.0%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.2%).
Kilroy Realty Corp is a leading U.S. real estate investment trust that develops, owns, and operates premium office, life science, and mixed-use properties primarily across high-growth West Coast markets including Los Angeles, San Francisco, Seattle, and San Diego. It serves tenants across the technology, life sciences, media, and creative sectors, with a core focus on delivering sustainable, future-ready workspaces tailored to modern business needs.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
KRC vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $272.2M | $493.8M |
| Net Profit | $17.1M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | — | 9.9% |
| Net Margin | 6.3% | 6.8% |
| Revenue YoY | -5.0% | -1.7% |
| Net Profit YoY | -73.7% | 10.5% |
| EPS (diluted) | $0.11 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $272.2M | $493.8M | ||
| Q3 25 | $279.7M | $492.9M | ||
| Q2 25 | $289.9M | $468.8M | ||
| Q1 25 | $270.8M | $458.4M | ||
| Q4 24 | $286.4M | $502.4M | ||
| Q3 24 | $289.9M | $511.2M | ||
| Q2 24 | $280.7M | $504.3M | ||
| Q1 24 | $278.6M | $495.1M |
| Q4 25 | $17.1M | $33.7M | ||
| Q3 25 | $162.3M | $71.7M | ||
| Q2 25 | $79.6M | $39.3M | ||
| Q1 25 | $43.7M | $20.7M | ||
| Q4 24 | $65.0M | $30.5M | ||
| Q3 24 | $57.7M | $19.4M | ||
| Q2 24 | $54.5M | $-153.0M | ||
| Q1 24 | $55.7M | $4.0M |
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 6.3% | 6.8% | ||
| Q3 25 | 58.0% | 14.5% | ||
| Q2 25 | 27.4% | 8.4% | ||
| Q1 25 | 16.1% | 4.5% | ||
| Q4 24 | 22.7% | 6.1% | ||
| Q3 24 | 19.9% | 3.8% | ||
| Q2 24 | 19.4% | -30.3% | ||
| Q1 24 | 20.0% | 0.8% |
| Q4 25 | $0.11 | $0.40 | ||
| Q3 25 | $1.31 | $0.84 | ||
| Q2 25 | $0.57 | $0.46 | ||
| Q1 25 | $0.33 | $0.24 | ||
| Q4 24 | $0.50 | $0.37 | ||
| Q3 24 | $0.44 | $0.23 | ||
| Q2 24 | $0.41 | $-1.84 | ||
| Q1 24 | $0.42 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $179.3M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $5.4B | $865.9M |
| Total Assets | $10.9B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $179.3M | $375.2M | ||
| Q3 25 | $372.4M | $340.1M | ||
| Q2 25 | $193.1M | $224.7M | ||
| Q1 25 | $146.7M | $99.0M | ||
| Q4 24 | $165.7M | $229.9M | ||
| Q3 24 | $625.4M | $103.8M | ||
| Q2 24 | $835.9M | $19.4M | ||
| Q1 24 | $855.0M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $5.4B | $865.9M | ||
| Q3 25 | $5.5B | $890.7M | ||
| Q2 25 | $5.4B | $833.8M | ||
| Q1 25 | $5.4B | $789.2M | ||
| Q4 24 | $5.4B | $764.9M | ||
| Q3 24 | $5.4B | $732.5M | ||
| Q2 24 | $5.4B | $706.5M | ||
| Q1 24 | $5.4B | $856.2M |
| Q4 25 | $10.9B | $2.2B | ||
| Q3 25 | $11.0B | $2.2B | ||
| Q2 25 | $10.9B | $2.1B | ||
| Q1 25 | $10.9B | $2.0B | ||
| Q4 24 | $10.9B | $2.2B | ||
| Q3 24 | $11.4B | $2.1B | ||
| Q2 24 | $11.5B | $2.0B | ||
| Q1 24 | $11.6B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $566.3M | $114.1M |
| Free Cash FlowOCF − Capex | $450.3M | — |
| FCF MarginFCF / Revenue | 165.4% | — |
| Capex IntensityCapex / Revenue | 42.6% | — |
| Cash ConversionOCF / Net Profit | 33.10× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $833.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $566.3M | $114.1M | ||
| Q3 25 | $176.6M | $137.3M | ||
| Q2 25 | $143.7M | $137.2M | ||
| Q1 25 | $136.9M | $-117.5M | ||
| Q4 24 | $541.1M | $133.0M | ||
| Q3 24 | $176.3M | $91.8M | ||
| Q2 24 | $88.7M | $107.0M | ||
| Q1 24 | $167.9M | $-125.2M |
| Q4 25 | $450.3M | — | ||
| Q3 25 | $148.7M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $115.6M | — | ||
| Q4 24 | $440.8M | — | ||
| Q3 24 | $147.2M | — | ||
| Q2 24 | $69.5M | — | ||
| Q1 24 | $151.9M | — |
| Q4 25 | 165.4% | — | ||
| Q3 25 | 53.1% | — | ||
| Q2 25 | 40.9% | — | ||
| Q1 25 | 42.7% | — | ||
| Q4 24 | 153.9% | — | ||
| Q3 24 | 50.8% | — | ||
| Q2 24 | 24.7% | — | ||
| Q1 24 | 54.5% | — |
| Q4 25 | 42.6% | — | ||
| Q3 25 | 10.0% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 35.0% | — | ||
| Q3 24 | 10.1% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | 5.7% | — |
| Q4 25 | 33.10× | 3.39× | ||
| Q3 25 | 1.09× | 1.91× | ||
| Q2 25 | 1.81× | 3.49× | ||
| Q1 25 | 3.13× | -5.66× | ||
| Q4 24 | 8.32× | 4.36× | ||
| Q3 24 | 3.06× | 4.72× | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 3.01× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KRC
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
